Changes in the Board of Directors and the Corporate Executive Committee of Roche
Jörg DuschmaléBasel, 9 December 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting on 17 March 2020.
Change in the Corporate Executive Committee
Dr Gottlieb A. Keller (65), General Counsel, member of the Corporate Executive Committee, and Secretary to the Board of Directors, will retire at the end of March 2020. The Board of Directors has appointed Claudia Böckstiegel (55), currently Head of Legal of the Diagnostics Division, to the position of General Counsel, and she will become a member of the Enlarged Corporate Executive Committee as of 1 April 2020.Attachments20191209-MR-Change_BOD+CEC_ENDr Jörg DuschmaléJörg DuschmaléDr Patrick FrostPatrick FrostClaudia BöckstiegelClaudia BöckstiegelDr Annette LutherAnnette Luther